← Insider buys
ODT

Odonate Therapeutics, Inc.

CEO and 10% owner Kevin C Tang bought $1.8M of Odonate Therapeutics, Inc.

Bought$1,759,296
$19.55Price
90,000Shares
+1%Stake

What ODT did for a copier

Prices for ODT after this filing aren't in yet.

Kevin C Tang's record

6 other buys with 3 months of prices since 2016: on average +1.2% against the S&P 500, and 2 of 6 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Tue, Sep 18. Filed Thu, Sep 20, 4:01 PM ET, after the close. Not investment advice.